Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer.
Tsilingiri K, Chalari A, Christopoulou G, Voutsina A, Constantoulakis P, Potaris Κ, Vamvakaris I, Hatzidaki D, Zachou G, Vatsellas G, Georgoulias V, Kotsakis A, Klinakis A.
Tsilingiri K, et al. Among authors: kotsakis a.
NPJ Precis Oncol. 2024 Dec 26;8(1):291. doi: 10.1038/s41698-024-00777-6.
NPJ Precis Oncol. 2024.
PMID: 39725687
Free PMC article.